Reduced sensitivity of SARS-CoV-2 Omicron variant to antibody neutralization elicited by booster vaccination-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Reduced sensitivity of SARS-CoV-2 Omicron variant to antibody neutralization elicited by booster vaccination

Published:2022-01-17 Issue:1 Volume:8 Page:
ISSN:2056-5968
Container-title:Cell Discovery
language:en
Short-container-title:Cell Discov

Author:

Yu Xiaoqi,Wei Dong,Xu Wenxin,Li Yulong,Li Xinxin,Zhang Xinxin^ORCID,Qu Jieming,Yang Zhitao,Chen Erzhen

Funder

Science and Technology Commission Shanghai Municipality

Shanghai Key Laboratory of Emergency Prevention, Diagnosis and Treatment of Respiratory Infectious Diseases

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Genetics,Molecular Biology,Biochemistry

Link

https://www.nature.com/articles/s41421-022-00375-5.pdf

Reference10 articles.

1. Zeng, G. et al. Immunogenicity and safety of a third dose of CoronaVac, and immune persistence of a two-dose schedule, in healthy adults: interim results from two single-centre, double-blind, randomised, placebo-controlled phase 2 clinical trials. Lancet Infect. Dis. https://doi.org/10.1016/S1473-3099(21)00681-2 (2021).

2. Pulliam, J. R. C. et al. Increased risk of SARS-CoV-2 reinfection associated with emergence of the Omicron variant in South Africa. medRxiv, https://doi.org/10.1101/2021.11.11.21266068 (2021).

3. Cao, Y. et al. Humoral immunogenicity and reactogenicity of CoronaVac or ZF2001 booster after two doses of inactivatedvaccine. Cell Res. 32, 107–109 (2021).

4. Ai, J. et al. Recombinant protein subunit vaccine booster following two-dose inactivated vaccines dramatically enhanced anti-RBD responses and neutralizing titers against SARS-CoV-2 and Variants of Concern. Cell Res. 32, 103–106 (2021).

5. Falsey, A. R. et al. SARS-CoV-2 neutralization with BNT162b2 vaccine dose 3. N. Engl. J. Med. 385, 1627–1629 (2021).

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dynamic Profiling and Prediction of Antibody Response to SARS-CoV-2 Booster-Inactivated Vaccines by Microsample-Driven Biosensor and Machine Learning;Vaccines;2024-03-25

2. Dynamic Profiling and Prediction of Antibody Response to Booster Inactivated Vaccines by Microsample-driven Biosensor and Machine Learning;2024-01-26

3. A potent neutralizing nanobody targeting a unique epitope on the receptor-binding domain of SARS-CoV-2 spike protein;Virology;2024-01

4. Azvudine and mortality in patients with coronavirus disease 2019: A retrospective cohort study;International Immunopharmacology;2023-11

5. Safety and immunogenicity of a heterologous booster with an RBD virus-like particle vaccine following two- or three-dose inactivated COVID-19 vaccine;Human Vaccines & Immunotherapeutics;2023-10-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3